CannaVcell enhances its IR activities by hiring INN and Flinnwest services
Vancouver, British Columbia--(Newsfile Corp. - June 25, 2019) - Canna-V-Cell Sciences Inc. (CSE: CNVC) ("CannaVcell") With the increase in its confidence of achieving the goals of the Cannabis biofarming development program, CannaVcell is hiring both Flinnwest and INN services. "This increase in confidence requires a further enhancement in the communication with the investment community" said Dr. Zaki Rakib the CEO while adding "as we are getting closer to demonstrate the feasibility and...
2019-06-25 9:00 AM EDT
Canna-V-Cell Increases Confidence in Its Biofarming Technology by Growing Cannabis Trichomes Containing Active Cannabinoids at the Callus Level
Vancouver, British Columbia--(Newsfile Corp. - May 28, 2019) - Canna-V-Cell Sciences Inc. (CSE: CNVC) (The "Company"), Canna-V-Cell is announcing today that as part of its program of applying the biofarming technology to Cannabis, it has achieved the critical milestone of ensuring the existence of active cannabinoids ingredients in its bank of cells required for the next step in the biofarming process. Active cannabinoids exist in the trichomes of the Cannabis plant. Trichomes, especially the...
2019-05-28 9:00 AM EDT
Canna-V-Cell Sciences Inc. announces Israel health ministry approval
Vancouver, British Columbia--(Newsfile Corp. - November 19, 2018) - Canna-V-Cell Sciences Inc. (CSE: CNVC) (the "CannaVcell") CannaVcell, in its aim to develop and produce Cannabis active ingredients on the basis of the biofarming technology, is announcing that it has received through its subsidiary in Israel, the authorization of the health ministry of Israel to conduct research and development with Cannabis plants. "This is a major milestone in the adaptation of the cell growth technology...
2018-11-19 8:30 AM EST